세계의 전기 생리학 시장 : 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Electrophysiology Market was valued at USD 6.9 billion in 2024 and is expected to grow at a CAGR of 10.4% from 2025 to 2034. Electrophysiology studies the electrical properties of biological tissues and cells, particularly focusing on nerve and muscle cells. This field uses various techniques such as electrocardiography (ECG), electromyography (EMG), and patch-clamp recordings to measure and analyze electrical signals.

The increasing prevalence of heart conditions like atrial fibrillation (AF) is a major driver of market growth. As the global population ages, the demand for advanced diagnostic and treatment options in electrophysiology is growing. Healthcare providers are focusing on better management of cardiac issues, which is boosting the adoption of electrophysiological techniques.

Technological innovations are also significantly fueling market expansion. Electrophysiology devices are becoming more advanced, improving treatment efficacy and safety. The popularity of catheter ablation procedures, which are minimally invasive, is rising as these techniques offer better outcomes for patients with arrhythmias and other heart conditions.

The market is segmented by product into electrophysiology (EP) ablation catheters, diagnostic catheters, and EP laboratory devices. EP ablation catheters accounted for the largest share, making up 49.1% of the market in 2024. These catheters are designed to deliver energy directly to the tissue causing irregular heartbeats. Modern technologies like high-resolution mapping systems improve the precision of ablation, targeting the abnormal electrical signals with minimal harm to surrounding healthy tissue.

Different types of ablation catheters, such as those using radiofrequency (RF), cryoablation, and laser energy, offer clinicians a range of options depending on the specific case and patient needs. Cryoablation, in particular, minimizes thermal damage, making it a preferred choice in some procedures. Many of these catheters now feature real-time monitoring capabilities, ensuring that the ablation process is both safe and effective.

By indication, the market is divided into atrial fibrillation, ventricular tachycardia, atrial flutter, and other conditions. The atrial fibrillation segment is the largest and is expected to see significant growth in the coming years due to the rising incidence of the condition worldwide.

Regarding end users, the electrophysiology market serves hospitals, catheterization laboratories, ambulatory surgery centers, and other healthcare facilities. Hospitals, in particular, dominate this segment, with specialized departments that offer advanced diagnostics and treatment options. These hospitals often have dedicated electrophysiology teams and state-of-the-art equipment that ensures high-quality care.

The U.S. market is expected to see substantial growth, supported by a well-established healthcare system, regulatory support, and advanced medical facilities. The country's infrastructure and the FDA's approval processes for new technologies create an environment conducive to innovation in the electrophysiology space, ensuring the continued development and adoption of cutting-edge devices and techniques.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of atrial fibrillation
    • 3.2.1.2 Technological advancements in electrophysiology devices
    • 3.2.1.3 Increasing preference for electrophysiology catheter ablation
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High investment for electrophysiology devices
    • 3.2.2.2 Dearth of skilled professionals in emerging nations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 EP ablation catheters
  • 5.2.1 Radiofrequency (RF)
  • 5.2.2 Cryoablation
  • 5.2.3 Laser
  • 5.2.4 Other EP ablation catheters
• 5.3 EP diagnostic catheters
  • 5.3.1 Conventional
  • 5.3.2 Advanced
  • 5.3.3 Ultrasound
• 5.4 EP laboratory devices
  • 5.4.1 Mapping systems
  • 5.4.2 Recording systems
  • 5.4.3 Other EP laboratory devices

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Atrial fibrillation
• 6.3 Ventricular tachycardia
• 6.4 Atrial tachycardia
• 6.5 Atrial flutter
• 6.6 WOLFF-Parkinson-white (WPW) syndrome
• 6.7 Atrioventricular nodal reentry tachycardia

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Catheterization/EP laboratories
• 7.4 Ambulatory surgery centers
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
  • 8.3.7 Ukraine
  • 8.3.8 Poland
  • 8.3.9 Switzerland
  • 8.3.10 Belgium
  • 8.3.11 Greece
  • 8.3.12 Czech Republic
  • 8.3.13 Netherlands
  • 8.3.14 Sweden
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Malaysia
  • 8.4.7 Indonesia
  • 8.4.8 Thailand
  • 8.4.9 Singapore
  • 8.4.10 Taiwan
  • 8.4.11 Philippines
  • 8.4.12 Vietnam
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Kuwait
  • 8.6.4 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 APN Health
• 9.3 Atricure
• 9.4 Biotronik
• 9.5 Boston Scientific Corporation
• 9.6 CardioFocus
• 9.7 GE Healthcare Technologies
• 9.8 Japan Lifeline
• 9.9 Johnson & Johnson
• 9.10 Koninklijke Philips
• 9.11 Medtronic
• 9.12 Microport Scientific Corporation
• 9.13 Merit Medical Systems
• 9.14 Siemens Healthineers
• 9.15 Stereotaxis